Medical News

RSS

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.

22 Jun 2011

Scientists apply math model to HIV to discover targets for vaccines or drugs

Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be a prime target for AIDS vaccines or drugs," the Wall Street Journal reports.

22 Jun 2011

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced positive topline results from a Phase IIb clinical trial with its lead product, LT-02, in patients with ulcerative colitis.

22 Jun 2011

State roundup: N.J. Gov. Christie's big health care changes

The state Senate voted 24-15 to pass legislation that will force public employees to pay more for their health insurance and pension. The vote, after hours of speeches from lawmakers on both sides, leaves only the Assembly to sign off on the bill that was a focal piece of Gov. Chris Christie's agenda.

22 Jun 2011

Dr. Reddy's Labs launches generic version of LEVAQUIN tablets in the U.S.

Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.

22 Jun 2011

FGS expands service offering to European market through ISO 13485 medical certification

Flextronics Global Services (FGS), a business unit of Flextronics, today announced that it is expanding its service offering to the medical market in Europe through ISO 13485 medical certification at its Budapest facility.

22 Jun 2011

Endocrine Practice journal publishes new clinical guidelines on hyperthyroidism

New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.

22 Jun 2011

Use public-private partnerships to improve access to essential health products

A new report from the International Vaccine Access Center "asks why products like Coca Cola can reach remote villages in developing nations while essential medicines like antibiotics cannot always be found," according to an IVAC press release.

22 Jun 2011

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase Ib clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus (HCV) infection.

22 Jun 2011

Human retina protein can sense Earth's magnetic field

For migratory birds and sea turtles, the ability to sense the Earth's magnetic field is crucial to navigating the long-distance voyages these animals undertake during migration. Humans, however, are widely assumed not to have an innate magnetic sense.

22 Jun 2011

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2011 Clinical Investigator Award Committee review.

22 Jun 2011

Pycnogenol, CoQ10 combination boost heart function

A recent study published in Panminerva Medica reveals that a Pycnogenol and Coenzyme Q10 combination taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

22 Jun 2011

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Results of African malaria vaccine trial expected later this year

The final phase of testing for GlaxoSmithKline Biologicals' malaria vaccine, RTS,S, is underway in seven sub-Saharan African countries, and "if the results, due to be released later this, year confirm the vaccine's efficacy in preventing malaria, it could be made available as early as 2015," IRIN reports.

22 Jun 2011

Gastric bypass surgery reduces inflammation linked with cancer and diabetes

New research shows that gastric bypass significantly reduces the inflammation associated with diseases including cancer and diabetes - more proof of the overall health benefits of such surgery beyond weight loss.

22 Jun 2011

Terry White Chemists, Orabrush partner to fight against bad breath

Orabrush, the tongue cleaner that helps cure bad breath, today announced Terry White Chemists has joined the battle against bad breath as the first Orabrush retailer in Australia.

22 Jun 2011

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a U.S. patent relating to a technology for the treatment of cancer for which the Company holds an exclusive, worldwide license.

22 Jun 2011

NCDs responsible for majority of deaths worldwide and cost trillions, report says

Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.

22 Jun 2011

Bureau of Labor Statistics: U.S. will need to add 580,000 nurses by 2018

The Bureau of Labor Statistics predicts the U.S. will need to add 580,000 nurses to the workforce by 2018. Moreover, these nurses will need higher skill levels than current nurses possess.

22 Jun 2011

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI Corporation announced today data from its Phase II clinical studies which showed that its lead drug Multikine was able to lower cholesterol in studies involving 120 head and neck cancer patients.

22 Jun 2011